Zhonggui He

42PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsGlycoconjugatesPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|May 01, 2026
Non-Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual-Pathway T Cell Activation.

|Apr 27, 2026
A Topology-to-Therapy Map for Prodrug Nanoassemblies.

|Feb 18, 2026
Reprogramming the In Vivo Fate of Nanoassemblies: Morphology Regulation to Rod-Like Nanostructures to Enhance Antitumor Efficacy.

Jingyi Zhang, Tian Liu, Yaqiao Li

|Jan 03, 2026
Hydrophobic/Amphiphilic Prodrug Coassembly Strategy: Exploring the Effect of Oligoethylene Glycol Chains on the Antitumor Efficacy of Nanoassemblies.

Jun Yuan, Shuo Wang, Wenjing Wang

|Sep 03, 2025
Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy.

Fengxiang Liu, Shipeng Ning, Xia Wang

|Aug 18, 2025
The Delicate Disulfide-Acryloyl Modification of Prodrug Facilitates Precise Albumin Targeting, Enhanced Tumor Accumulation, and Reduced Toxicity.

Yanzhong Hao, Yaqiao Li, Lu Li

Pageof 7

Frequent Collaborators

31 joint publications

Jin Sun

9 joint publications

Bingjun Sun

4 joint publications

Kaiyuan Wang

2 joint publications

Jin Sun